Reuters logo
BRIEF-Shanghai Fosun Pharmaceutical responds to media reports
March 30, 2017 / 9:36 AM / 8 months ago

BRIEF-Shanghai Fosun Pharmaceutical responds to media reports

March 30 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:

* Reference is made to announcements of Shanghai Fosun Pharmaceutical (Group) Co., dated 28 July 2016

* Recently, there have been media reports provide that acquisition was approved by relevant competent authorities of India

* Acquisition was approved by shareholders at 2016 third extraordinary general meeting of company

* Relevant approvals of competent authorities of PRC in relation to acquisition have been obtained

* Acquisition was reviewed by Indian foreign investment promotion board

* Filings with competent antitrust authorities of united states have been completed

* Acquisition will be recommended to cabinet committee on economic affairs of India for further review and approval Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below